SARS-CoV-2 ORF7a 抗体 (AA 16-111)
Quick Overview for SARS-CoV-2 ORF7a 抗体 (AA 16-111) (ABIN7469591)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 16-111
-
交叉反应
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
-
纯化方法
- Affinity purified by Protein G.
-
免疫原
- The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).
-
亚型
- IgG1
-
-
-
-
应用备注
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
说明
-
Positive Control: ORF7a-transfected 293T cell
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS, No Preservative
-
储存液
- Without preservative
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SARS-CoV-2 ORF7a
-
背景
- 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a
抗原
-